The new project will focus on producing a rhCollagen-based 3D bioprinted human intestine model that will facilitate drug discovery and promote personalized medicine applications for the treatment of ulcerative colitis.
Latest news
CollPlant, Tel Aviv University, and Sheba Join Forces to Personalize Ulcerative Colitis Treatment
read more
Memorandum of Understanding with New South Wales Government Will Bring Innovative Healthcare to Australia
Taking an important step towards bringing greater healthcare equity to the region through medical innovation, Sheba’s ARC Innovation signed an MOU with the New South Wales Government.
Healthy Aging: A New Longevity Center Opens at Sheba
Modern medicine has increased life expectancy. However, healthspan expansion has not increased at the same rate due to chronic diseases, including heart disease, stroke, cancer, and dementia.
For the Fifth Consecutive Year: Sheba Ranked as One of the World’s Best Hospitals by Newsweek Magazine
“This is yet another testament to the hard work of our talented and forward-thinking medical teams,” commented Sheba Director General, Prof. Yitshak Kreiss, shortly upon receiving the news.
The New Chicago ARC Innovation Center
Chicago ARC, a newly launched venture in Chicago based on Sheba’s ARC model, aims to bring together health systems, corporations, innovative startups, and community organizations to address health disparities.
Sheba Partners with US and Kenyan Navies for Mass Casualty Drill
In a first-of-its-kind initiative, Sheba representatives joined forces with the U.S. Navy’s 5th Fleet (NAVCENT) to prepare the Kenyan Navy and local healthcare workers for a mass casualty scenario.
